Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

BSAVA’s CEO to leave organisation after 14 years
“(...)it’s been an honour to have played a part in supporting such a wonderful profession.” – Amanda Stranack, BSAVA CEO.
Amanda Stranack’s final day will be 30 April 2026.

The British Small Animal Veterinary Association (BSAVA) is to transition to a new chief executive officer (CEO), with Stacy Woodman sitting interim CEO.

Ms Woodman will support the organisation through the transition as Amanda Stranack prepares to leave after 14 years with BSAVA.

Amanda Stranack first joined the organisation in 2012 as head of congress, before becoming director of operations in 2016. She was appointed CEO in 2019, where she became closely involved with the organisation’s strategic development.

During Ms Stranack’s time as CEO, membership for BSAVA has increased to more than 10,000 members. She has also contributed to plans that will shape the organisation’s future.

Ms Stranack said: “I’m proud of what we’ve achieved together and grateful to the team, volunteers, partners and veterinary community who have supported our work. The dedication and expertise within the BSAVA have been inspiring and it’s been an honour to have played a part in supporting such a wonderful profession.”

Stacy Woodman will be stepping in as interim CEO before a permanent appointment is made.

Ms Woodman has been leading BSAVA’s Programme of Change, working closely with the Board and leadership team to shape a new business plan and strategy. BSAVA says that her expertise and organisational knowledge will provide ‘continuity’ during the transition.

The BSAVA has begun recruiting a permanent CEO, with a further update to follow in due course.

Stacy Woodman said: “I’m pleased to be stepping into the Interim CEO role and supporting the organisation through this next phase. Having worked closely with the Board and leadership team on the Programme of Change, I understand both the ambition and the realities behind the plan. The BSAVA has a capable team and a clear direction, and I’m looking forward to working together to deliver on what we’ve set out to achieve.”

Julian Hoad, BSAVA president, said: “Amanda’s contribution to the BSAVA over the past 14 years has been exceptional. She has led with professionalism, warmth and a deep commitment to the veterinary profession. From her early work as Head of Congress through to CEO, she has played a major role in shaping the BSAVA’s progress and helping position the Association for its next phase.

“We thank Amanda for everything she has given to the BSAVA and wish her well for the future. And as we move into that next phase, we are delighted to welcome Stacy as our Interim CEO.”

Image © BSAVA

Become a member or log in to add this story to your CPD history

Voting opens for BEVA Council

News Story 1
 Eligible members of BEVA will be able to vote for their Council team until Monday, 17 August 2026. Members will have received an election email on 17 July.

There are five candidates standing for four available places on Council. They are:

  • Alexandre Triguino
  • Angela Jones
  • Beth Bryant
  • Holly Rees
  • Hugh Somerville
Full profiles for each candidate can be found on the BEVA website

Click here for more...
News Shorts
Milk recalled over presence of veterinary medicines

Graham's Family Dairy has issued a recall for its semi-skimmed milk due to the presence of veterinary medicines in the product.

In a risk statement, the Food Standards Agency said the presence of the medicines, including penicillin, make the milk unsafe to consume and 'may be a possible health risk for anyone with an allergy to antibiotics'.

Customers who bought the product are advised to return it to the store of purchase for a full refund.